Cassava Sciences Inc (SAVA) Stock Price, Quote & News

Company Profile

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company w...

Industry: Biotechnology

Sector: Healthcare

Phone: 512 501 2444

Website: www.cassavasciences.com

Address:

6801 N. Capital of Texas Highway, Suite 300 Building 1, Austin, United States

History101 Feb. 19 at 9:38 PM

$SAVA like i said...

0 · Reply

JunkPost Feb. 19 at 8:45 PM

$SAVA $8 Gap fill would be great

0 · Reply

DarkSonar Feb. 19 at 8:37 PM

$SAVA Please don’t run up yet!! Let me get out of my other position first!! This is looking primed 🧨

0 · Reply

JunkPost Feb. 19 at 8:35 PM

$SAVA Wants to go up

0 · Reply

2bitinvestor Feb. 19 at 5:48 PM

$SAVA And I didn't miss the big one with SAVA You did.. Remember that.. LOL And I invested it in 2 annuities for later on. 🤠

0 · Reply

2bitinvestor Feb. 19 at 5:46 PM

$SAVA BoobyTek.. You need help. You just a pump a chump..You don't like my opinon block me. You were the turd calling me a liar weren't you.. LOL Chump

0 · Reply

StocktwitsNews Feb. 19 at 5:05 PM

Cassava Sciences Says DOJ Has Closed Probe Into Allegations Around Its Alzheimer’s Program $SAVA $VTI $VXF https://stocktwits.com/news/equity/markets/cassava-sciences-says-doj-closed-probe-into-allegations-around-alzheimers-program/cZRk5KZR4D7

0 · Reply

bobbythek Feb. 19 at 3:59 PM

$SAVA We dont need saviors here. We are smart enough to make our own decisions. Sorry you will miss this next move much higher 2BitInvestor.

0 · Reply

2bitinvestor Feb. 19 at 3:39 PM

$SAVA A lot of pumpers in here. Don't listen to them. Do your own research. They settled because they were guilty..Period. And their drug did not work as they had been saying for years. I was in it during that time since it was PTIE.. Glad I sold back when it was hitting all time highs like $145 per share. (see the photo) I did make almost half million. Bought some again later and only lost around 20K. Don't listen to those BS pumpers. All of the SAVA loyalists got burned after those warrant BS they came up with . I post the screen shot because some moron in here called me a liar saying it never hit $145.. Well it did. It never closed that high but it damn sure traded at that price.

0 · Reply

2bitinvestor Feb. 19 at 3:25 PM

$SAVA Well. I'm sorry but settling does NOT mean the allegations were false. In fact, IMO it means they were. And now you are hoping Similifilm is good for Epilepsy and other conditions? Come on. Good luck with this one. So glad to be done with this. I would not invest in it again. "As previously disclosed, the Company reached a settlement with the U.S. Securities and Exchange Commission (SEC) of negligence-based disclosure charges in September 2024 and paid a monetary penalty without admitting or denying the SEC’s allegations. The Company cooperated fully with both the DOJ and SEC investigations. These outcomes end the investigations of the Company by the DOJ and SEC. “We welcome the resolution of these investigations and remain dedicated to maintaining the trust of all our stakeholders. As we move forward, we will continue to focus our efforts on developing a novel treatment for TSC-related epilepsy,” said Richard J. Barry, President and Chief Executive Officer of Cassava."

0 · Reply

Cassava Sciences says US DOJ has closed investigation into company

Dec 24, 2025, 11:51 AM EST - 2 months ago

HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 19, 2025, 11:31 AM EST - 2 months ago

FDA Puts Cassava's Simufilam Epilepsy Trial On Full Clinical Hold

Oct 22, 2025, 4:05 PM EDT - 4 months ago

Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 22, 2025, 8:00 AM EDT - 4 months ago

Cassava Sciences Appoints Dawn C. Bir to the Board of Directors

Aug 14, 2025, 7:30 AM EDT - 6 months ago

Cassava Reports Q2 2025 Financials Results and Provides Business Update

Aug 7, 2025, 7:30 AM EDT - 7 months ago

Cassava Sciences Appoints Dr. Joseph Hulihan as Chief Medical Officer

Aug 4, 2025, 7:30 AM EDT - 7 months ago

Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy

Jun 30, 2025, 7:00 AM EDT - 8 months ago

Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting

May 1, 2025, 7:30 AM EDT - 10 months ago

Cassava Appoints Angélique Bordey, PhD, to Enhance Preclinical Program in TSC

Apr 21, 2025, 4:30 PM EDT - 10 months ago

Cassava Announces Retirement of Chief Medical Officer, Dr. Jim Kupiec, and Appointment of Dr. Jack Moore as Senior Vice President, Clinical Development

Mar 26, 2025, 3:49 PM EDT - 11 months ago

Cassava Sciences must face malicious prosecution lawsuit over Alzheimer's drug

Mar 25, 2025, 10:42 AM EDT - 11 months ago

Cassava Sciences Discontinues Developing Simufilam For Alzheimer's After Another Phase 3 Trial Flop

Mar 25, 2025, 8:05 AM EDT - 11 months ago

Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

Mar 3, 2025, 7:30 AM EST - 1 year ago

Cassava Sciences Reports 2024 Financial Results and Provides Business Update

Feb 9, 2025, 10:45 AM EST - 1 year ago

Lead Plaintiff Deadline on February 10, 2025 for SAVA Investors - Kessler Topaz Meltzer & Check, LLP Encourages Investors with Losses to Contact the Firm

Feb 7, 2025, 12:08 PM EST - 1 year ago

SAVA Deadline: Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Feb 3, 2025, 5:45 AM EST - 1 year ago

Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA

Jan 23, 2025, 2:47 PM EST - 1 year ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Jan 7, 2025, 4:30 PM EST - 1 year ago

Cassava Sciences Provides a Business Update

Dec 23, 2024, 5:45 AM EST - 1 year ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. Lawsuit - SAVA

Dec 18, 2024, 10:53 AM EST - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Dec 13, 2024, 1:16 PM EST - 1 year ago

Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

History101 Feb. 19 at 9:38 PM

$SAVA like i said...

0 · Reply

JunkPost Feb. 19 at 8:45 PM

$SAVA $8 Gap fill would be great

0 · Reply

DarkSonar Feb. 19 at 8:37 PM

$SAVA Please don’t run up yet!! Let me get out of my other position first!! This is looking primed 🧨

0 · Reply

JunkPost Feb. 19 at 8:35 PM

$SAVA Wants to go up

0 · Reply

2bitinvestor Feb. 19 at 5:48 PM

$SAVA And I didn't miss the big one with SAVA You did.. Remember that.. LOL And I invested it in 2 annuities for later on. 🤠

0 · Reply

2bitinvestor Feb. 19 at 5:46 PM

$SAVA BoobyTek.. You need help. You just a pump a chump..You don't like my opinon block me. You were the turd calling me a liar weren't you.. LOL Chump

0 · Reply

StocktwitsNews Feb. 19 at 5:05 PM

0 · Reply

bobbythek Feb. 19 at 3:59 PM

$SAVA We dont need saviors here. We are smart enough to make our own decisions. Sorry you will miss this next move much higher 2BitInvestor.

0 · Reply

2bitinvestor Feb. 19 at 3:39 PM

0 · Reply

2bitinvestor Feb. 19 at 3:25 PM

0 · Reply

Bricktop200 Feb. 19 at 2:30 PM

$SAVA they can suppress the price all they want, I can smell victory in the long run.

0 · Reply

History101 Feb. 19 at 2:22 PM

$SAVA we all knew at the time that Wang & SAVA were not guilty, as PR below shows, SAVA was persecuted for zero reason, this sham "investigation" was done at the behest of the frauds at big pharma. DOJ & SEC got some $$ as always for because these corrupt orgs know that companies always settle. So many REAL laws are broken every day in the stock market, in the patent arena, etc, but the companies that commit those far greater crimes have bought the agencies and congress so zero consequences for them. https://finance.yahoo.com/news/cassava-announces-closure-u-department-130000788.html

0 · Reply

DragonAlgo Feb. 19 at 2:14 PM

🐉 $SAVA CALL — DragonAlgo® Signal Contract: SAVA CALL Expiry: 2026-02-20 | Strike: $2.50 | Type: CALL Option Plan (premium): Entry: $0.02 Stop: $0.01 TP1: $0.03 TP2: $0.03 TP3: $0.05 🔗 https://dragonalgo.com

0 · Reply

oldwisetrader Feb. 19 at 1:59 PM

$SAVA just watching sava as it’s been on my list, will point out that removal of legal issues opens up the door to deals and mergers etc… like this stock on strength above. 2.30 today if it happens

0 · Reply